Articles Tagged With:
-
Blood Test for Pregnant Women May Predict Preterm Births
In pilot studies of pregnant women, data indicate that ribonucleic acid-based tests of maternal blood can predict delivery date and risk of early childbirth.
-
Medical Coalition Addresses CMS Price Transparency Proposal
Consumers may want upfront pricing details, but who is responsible for providing that information?
-
Add the IUD to EC Counseling
Results of a new study indicate that many young women don’t know that the IUD can be used for emergency contraception or that it is effective. Researchers report that if young women needed emergency contraception, most indicated they would want to know about IUDs in addition to emergency contraceptive pills.
-
Join the Mission: Increase HPV Vaccinations for Girls and Boys
The 67 National Cancer Institute-designated cancer centers and a host of other cancer organizations now are fully endorsing the goal of eliminating cancers caused by human papillomavirus (HPV) through gender-neutral HPV vaccination and evidence-based cancer screening.
-
Emotional Freedom Technique and Post-traumatic Stress Disorder
The emotional freedom technique is a new approach to treating post-traumatic stress disorder in veterans that uses genomic science.
-
sTMS for Migraine Prevention
This observational study adds evidence for daily use of single-pulse, transcranial stimulation (sTMS) for the prevention of migraines.
-
Is Electroacupuncture the Answer to Stress Urinary Incontinence?
Following six weeks of every other day treatment, women treated with electroacupuncture in the sacral region reported less urinary incontinence than women receiving sham acupuncture in the same region.
-
All That Is Round Is Not Fungus: A Differential Diagnosis of Annular Lesions
Annular skin lesions commonly plague many primary care patients, but not all that is round is fungus. This article highlights the differential diagnosis of conditions that can mimic tinea.
-
FDA Proposes Including Children in Adult Cancer Trials
IRB members have until Aug. 3, 2018, to submit comments on FDA draft guidance that would open adult oncology clinical trials to children ages 12 to 17 years.
-
IRBs Can Learn to Make the Most of Central IRB Partnerships
The IRB at Inova Health System of Falls Church, VA, began working with a central IRB 15 years ago — long before the new Common Rule encouraged IRBs to designate an IRB of record for multisite studies.